# HYDROCHLOROTHIAZIDE

NDC: 0615-8449
Generic name: HYDROCHLOROTHIAZIDE
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191101

FDA application: ANDA040702

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8449"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8449
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c1a92c0-b491-4ae9-8bd0-029beb2b13c6